Deadline Approaching for AstraZeneca Shareholders in Class Action Lawsuit Led by Kahn Swick & Foti

AstraZeneca Class Action Suit Reminder

Former Louisiana Attorney General Charles C. Foti, Jr. and his law firm, Kahn Swick & Foti, LLC (KSF), are issuing an urgent reminder to investors in AstraZeneca PLC (NASDAQ: AZN) regarding the lead plaintiff deadline for a significant class action lawsuit. Investors who endured losses exceeding $100,000 by purchasing AstraZeneca's securities between February 23, 2022, and December 17, 2024, should be aware that the window to file their applications ends on February 21, 2025.

The lawsuit is currently being pursued in the United States District Court for the Central District of California. The nature of the case revolves around allegations that AstraZeneca and some of its executives failed to reveal crucial information that affected stock performance during the class period, breaching US federal securities laws.

Details of the Allegations

AstraZeneca is charged with various misleading and false statements. These include accusations of engaging in insurance fraud in China, which is said to have led to heightened legal risks and the eventual detention of the President of AstraZeneca China by Chinese authorities. Furthermore, it is alleged that these undisclosed risks resulted in the company underestimating its legal exposure, which could materially harm its business in China. With these claims coming to light, investors experienced significant losses, prompting this lawsuit.

The case is officially delineated as Saleh v. AstraZeneca PLC, et al., No. 24-cv-11021.

Investor Actions

For shareholders interested in understanding their legal rights in this matter, KSF offers consultations without obligation. To learn more about how this lawsuit might affect personal investments, individuals can contact KSF’s Managing Partner, Lewis Kahn, at 1-877-515-1850 or via email at email protected]. Additional information can be found on their website at [ksfcounsel.com.

Investors wishing to become lead plaintiffs must formally petition the court before the deadline. Kahn Swick & Foti, a distinguished boutique law firm specializing in securities litigation, has a track record of advocating for various clients, including institutional investors and retail shareholders, in recovering losses attributed to corporate malfeasance.

Currently, KSF operates multiple offices across the United States, including locations in New York, California, Louisiana, and Illinois. As one of the leading firms in this niche, they focus on obtaining justice for those affected by fraud in publicly traded companies.

By paying attention to upcoming deadlines and participating actively, investors can safeguard their rights and potentially recoup their losses through this ongoing legal process.